2024-07-11 |
SDZHSE24060419 |
VITRUVIAS THERAPEUTICS INC |
1525.0 kg |
701310
|
300MG-BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLET USP 300MG , NOS; TEMP: +22 C VEN T: CLOSED |
2024-06-16 |
ZHJLNBF24051273 |
VITRUVIAS THERAPEUTICS INC |
3686.0 kg |
293739
|
BUPROPION HYDROCHLORIDE EXTENDEDRELEASE TABLE. |
2024-06-12 |
ZHJLNBF24050870 |
VITRUVIAS THERAPEUTICS INC |
3009.0 kg |
930400
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABL. |
2023-12-19 |
OERT201701M10557 |
VITRUVIAS THERAPEUTICS INC |
3810.0 kg |
291229
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLET USP 150M G BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLET USP 300MG |
2023-09-11 |
OERT201701M05131 |
VITRUVIAS THERAPEUTICS INC |
4515.0 kg |
291229
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLET USP 150MG BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLET USP 300MG |
2023-09-11 |
OERT201701M05671 |
VITRUVIAS THERAPEUTICS INC |
1662.0 kg |
291229
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLET USP 150MG |
2023-01-13 |
TXSLTSE22105552A |
LANNETT COMPANY INC |
1495.0 kg |
310510
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, USP 150 MG BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, USP 300 MG PO#4500499506,4500499507 92CARTONS=6PALLETS |
2022-10-06 |
TXSLTSE220604616 |
LANNETT COMPANY INC |
580.0 kg |
310510
|
POSACONAZOLE DELAYED-RELEASE TABLETS, 100MG PO#4500498286 |
2022-09-27 |
TXSLTSE220805029 |
LANNETT COMPANY INC |
767.0 kg |
310510
|
POSACONAZOLE DELAYED-RELEASE TABLETS, 100MG PO#4500498939/4500498940 |
2022-06-26 |
TXSLTSE220504452 |
LANNETT COMPANY INC |
966.0 kg |
310510
|
POSACONAZOLE DELAYED-RELEASE TABLETS, 100MG PO#4500498003 |
2022-06-03 |
TLKPSHAATL24276X |
LANNETT COMPANY INC |
963.0 kg |
310510
|
POSACONAZOLE DELAYED-RELEASE TABLETS, 100MG |
2022-05-21 |
CMDUNCHN306821 |
LANNETT COMPANY INC |
2399.0 kg |
262060
|
------------ CGMU5267100 DESCRIPTION---------BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLET 150MG POSACONAZOLE DELAYED-RELEASE ABLETS, 100 MG FREIGHT PREPAID KYLE.STANFIELD LANNETT.COM, GLORIEMAR.DELATORRE LANNETT.COM, TSM SINOTPH.COM,JIAO.WU SINOTPH.COM -------------GENERIC DESCRIPTION------------- CARGO IS STOWED IN A REFRIGERATED CONTAINER SAT THE SHIPPER S REQUESTED CARRYING TEMPERATUOF 22 DEGREES CELSIUS |
2022-05-02 |
EXDO6395692111 |
LANNETT COMPANY INC |
3695.0 kg |
930400
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABL. |
2022-02-23 |
DFDSSHA7879113 |
LANNETT COMPANY INC |
386.0 kg |
930400
|
POSACONAZOLE DELAYED-RELEASE TABLET |
2021-12-14 |
DFDSSHA7822118 |
LANNETT COMPANY INC |
1021.0 kg |
930400
|
POSACONAZOLE DELAYED-RELEASE TABLET |
2021-10-28 |
BANQSHA8628201 |
SANDOZ INC |
2674.0 kg |
300490
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLET USP 300MG 150MG PO NO. 1050059346 & 9911578091 1050059347 & 9911578092 1050059309 & 9911575759 1050059307 & 9911575770 1050059308 & 9911575771 HS-CODE 300490 TEMP 20C VENT CLOSED AUTO NVOCC BANQSHA8628201 . LESTER PA 19113 UNITED STATES |
2021-09-17 |
DFDSSHA7763231 |
LANNETT COMPANY INC |
563.0 kg |
930400
|
POSACONAZOLE DELAYED-RELEASE TABLET |
2021-09-01 |
OERT201701K07055 |
VITRUVIAS THERAPEUTICS INC |
1832.0 kg |
291229
|
PROPAFENONE HYDROCHILORIDE EXTENDED-RELEASE CAPSULES USP 325MG 60 C |
2021-08-03 |
DFDSSHA7726652 |
LANNETT COMPANY INC |
677.0 kg |
930400
|
POSACONAZOLE DELAYED-RELEASE TABLET |
2021-07-04 |
DFDSSHA7699239 |
LANNETT COMPANY INC |
835.0 kg |
930400
|
POSACONAZOLE DELAYED-RELEASE TABLET |
2021-04-24 |
DFDSSHA7673299 |
SANDOZ INC |
4813.0 kg |
291229
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLET USP 300MG/150MG BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLET USP 300MG/150MG |
2021-04-17 |
DFDSSHA7674490 |
LANNETT COMPANY INC |
745.0 kg |
930400
|
POSACONAZOLE DELAYED-RELEASE TABLET |
2021-03-15 |
DFDSSHA7646012 |
LANNETT COMPANY INC |
358.0 kg |
930400
|
POSACONAZOLE DELAYED-RELEASE TABLET |
2021-01-21 |
OERT201701J10315 |
VITRUVIAS THERAPEUTICS INC |
1336.0 kg |
291229
|
PROPAFENONE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP 325MG 60 |
2021-01-21 |
DFDSSHA7602435 |
LANNETT COMPANY INC |
761.0 kg |
930400
|
POSACONAZOLE DELAYED-RELEASE TABLET |